- This event has passed.
ASPC Breakfast Symposium: Town Hall Series on Improving Access to PCKS9 Inhibitors Issues & Recommendations
Monday, November 13, 2017 @ 6:30 am - 8:30 am
In 2016, the American Society for Preventive Cardiology (ASPC) sought to address patient barrier to access PCSK9 inhibitors by bringing together various stakeholder organizations for two Town Hall events entitled “Unraveling a Therapeutic Conundrum: Barriers to Access PCSK9 Inhibitors.” The ASPC and other stakeholder groups – National Lipid Association, American Association of Clinical Endocrinologist
s, American College of Cardiology, and FH Foundation — identified access issues and recommended pragmatic solutions. From the 2016 series, the ASPC and stakeholders produced a publication to summarize the identified access issues and recommended solutions entitled “PCSK9 Inhibitor Access Barriers: Issues and Recommendations : Improving the Access Process for Patients, Clinicians, and Payers.”
Join us as we discuss this publication that summarizes barriers to access PCSK9 inhibitors, and learn about new tools and resources to overcome this hurdle in accessibility. Read our paper on the latest findings and solutions to accessing PCSK9 inhibitors by clicking here. This non-CME breakfast symposium.
This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.
This activity is sponsored by Amgen, Sanofi and Regeneron.